205 related articles for article (PubMed ID: 31964364)
21. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
[TBL] [Abstract][Full Text] [Related]
22. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection.
Uprety P; Patel K; Karalius B; Ziemniak C; Chen YH; Brummel SS; Siminski S; Van Dyke RB; Seage GR; Persaud D;
Clin Infect Dis; 2017 Jun; 64(11):1471-1478. PubMed ID: 28329153
[TBL] [Abstract][Full Text] [Related]
23. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
[TBL] [Abstract][Full Text] [Related]
25. Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.
Cuzin L; Pugliese P; Sauné K; Allavena C; Ghosn J; Cottalorda J; Rodallec A; Chaix ML; Fafi-Kremer S; Soulié C; Ouka M; Charpentier C; Bocket L; Mirand A; Guiguet M;
AIDS; 2015 Aug; 29(13):1665-71. PubMed ID: 26372277
[TBL] [Abstract][Full Text] [Related]
26. A higher CD4/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study.
Yue Y; Wang N; Han Y; Zhu T; Xie J; Qiu Z; Song X; Li Y; Routy JP; Wang J; Li T
BMC Infect Dis; 2017 Dec; 17(1):771. PubMed ID: 29246197
[TBL] [Abstract][Full Text] [Related]
27. Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China.
Li X; Xue Y; Zhou L; Lin Y; Yu X; Wang X; Zhen X; Zhang W; Ning Z; Yue Q; Fu J; Shen F; Gai J; Xu Y; Mao J; Gao X; Shen X; Kang L; Vanham G; Cheng H; Wang Y; Zhuang M; Zhuang X; Pan Q; Zhong P
PLoS One; 2014; 9(2):e89462. PubMed ID: 24586795
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.
Lam EP; Moore CL; Gotuzzo E; Nwizu C; Kamarulzaman A; Chetchotisakd P; van Wyk J; Teppler H; Kumarasamy N; Molina JM; Emery S; Cooper DA; Boyd MA
AIDS Res Hum Retroviruses; 2016 Sep; 32(9):841-50. PubMed ID: 27346600
[TBL] [Abstract][Full Text] [Related]
29. Disparate impact on CD4 T cell count by two distinct HIV-1 phylogenetic clusters from the same clade.
Song H; Ou W; Feng Y; Zhang J; Li F; Hu J; Peng H; Xing H; Ma L; Tan Q; Li D; Wang L; Wu B; Shao Y
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):239-244. PubMed ID: 30559208
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 Subtype Shift in the Philippines is Associated With High Transmitted Drug Resistance, High Viral Loads, and Fast Immunologic Decline.
Salvaña EMT; Dungca NT; Arevalo G; Li K; Francisco C; Penalosa C; Dela Tonga A; Leyritana K; Solante R; Tactacan-Abrenica RJ; Lim J; Alejandria M; Palaypayon N; Schwem B
Int J Infect Dis; 2022 Sep; 122():936-943. PubMed ID: 35788414
[TBL] [Abstract][Full Text] [Related]
31. Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy.
Masquelier B; Taieb A; Reigadas S; Marchou B; Cheneau C; Spire B; Charpentier C; Leport C; Raffi F; Chêne G; Descamps D;
J Antimicrob Chemother; 2011 Jul; 66(7):1582-9. PubMed ID: 21525020
[TBL] [Abstract][Full Text] [Related]
32. Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens.
Bunupuradah T; Ananworanich J; Chetchotisakd P; Kantipong P; Jirajariyavej S; Sirivichayakul S; Munsakul W; Prasithsirikul W; Sungkanuparph S; Bowonwattanuwong C; Klinbuayaem V; Petoumenos K; Hirschel B; Bhakeecheep S; Ruxrungtham K
Antivir Ther; 2011; 16(7):1113-21. PubMed ID: 22024527
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 DNA concentrations and evolution among African HIV-1-infected children under antiretroviral treatment (ANRS 1244/1278).
Boullé C; Rouet F; Fassinou P; Msellati P; Debeaudrap P; Chaix ML; Rouzioux C; Avettand-Fenoel V
J Antimicrob Chemother; 2014 Nov; 69(11):3047-50. PubMed ID: 25038068
[TBL] [Abstract][Full Text] [Related]
34. Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.
Laanani M; Ghosn J; Essat A; Melard A; Seng R; Gousset M; Panjo H; Mortier E; Girard PM; Goujard C; Meyer L; Rouzioux C;
Clin Infect Dis; 2015 Jun; 60(11):1715-21. PubMed ID: 25737374
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART.
Lombardi F; Belmonti S; Rapone L; Borghetti A; Ciccullo A; Gagliardini R; Baldin G; Montagnani F; Moschese D; Emiliozzi A; Rossetti B; De Luca A; Di Giambenedetto S
J Clin Virol; 2018 Jun; 103():57-62. PubMed ID: 29656086
[TBL] [Abstract][Full Text] [Related]
36. Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy.
Palmisano L; Giuliano M; Chiarotti F; Zanchetta M; Andreotti M; Pirillo MF; Riva E; Antonelli G; De Rossi A; Vella S
J Acquir Immune Defic Syndr; 2008 May; 48(1):68-71. PubMed ID: 18360287
[TBL] [Abstract][Full Text] [Related]
37. The spread of HIV-1 subtypes B and CRF01_AE among injecting drug users in Bangkok, Thailand.
Xiridou M; van Griensven F; Tappero JW; Martin M; Gurwith M; Vanichseni S; Kittikraisak W; Coutinho R; Choopanya K
J Acquir Immune Defic Syndr; 2007 Aug; 45(4):468-75. PubMed ID: 17496560
[TBL] [Abstract][Full Text] [Related]
38. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.
Easterbrook PJ; Smith M; Mullen J; O'Shea S; Chrystie I; de Ruiter A; Tatt ID; Geretti AM; Zuckerman M
J Int AIDS Soc; 2010 Feb; 13():4. PubMed ID: 20205896
[TBL] [Abstract][Full Text] [Related]
39. Rapid identification of human immunodeficiency virus type 1 CRF01_AE and BC recombinants by subtype-specific PCR.
Luo H; Su QJ; Shao YM; Xing H; Chen J; Liu W; Zhang ZY; Zang N; Xiao X; Liang H
J Virol Methods; 2011 Feb; 171(2):339-44. PubMed ID: 21126539
[TBL] [Abstract][Full Text] [Related]
40. [Molecular characteristics of HIV-1 CRF01 _ AE strains in Zhejiang province].
Yao YP; Xin RL; He X; Meng ZF; Pan XH; Guo ZH; Yang JZ; Xu Y; Xing H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Feb; 29(2):161-5. PubMed ID: 18686858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
